Merck & Co. Inc. closed 41.19% below its 52-week high of $134.63, which the company reached on June 25th.

Merck is juggling shareholder rebellion and market turbulence ahead of its annual meeting, with the company giving a firm thumbs-down to several investor proposals. This shareholder pushback adds a ...